Real-world elderly myeloma patients: improved survival despite more adverse risk factors than younger patients and RCT populations. A study on behalf of the Nordic Myeloma Study Group

Kari Lenita Falck Moore; Cecilie Hveding Blimark; Annette Juul Vangsted; Ingemar Turesson; Tobias Klausen; Louise Redder; Dorota Knut-Bojanowska; Ingigerdur Sverrisdottir; Anna Genell

doi:10.1016/S2152-2650(21)02294-1

Real-world elderly myeloma patients: improved survival despite more adverse risk factors than younger patients and RCT populations. A study on behalf of the Nordic Myeloma Study Group

Kari Lenita Falck Moore
, Cecilie Hveding Blimark
, Annette Juul Vangsted
, Ingemar Turesson
, Tobias Klausen
, Louise Redder
, Dorota Knut-Bojanowska
, Ingigerdur Sverrisdottir
, Anna Genell

KI, OUH, Research unit of Haematology (Odense)

University of Oslo
Sahlgrenska University Hospital
Rigshospitalet
Lund University
Herlev Hospital
Uddevalla Hospital

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	P-167
Journal	Clinical Lymphoma Myeloma and Leukemia
Volume	21
Issue number	Suppl. 2
Pages (from-to)	S127-S128
ISSN	2152-2650
DOIs	https://doi.org/10.1016/S2152-2650(21)02294-1
Publication status	Published - Oct 2021
Event	18th International Myeloma Workshop - Vienna, Austria Duration: 8. Sept 2021 → 11. Sept 2021

Workshop

Workshop	18th International Myeloma Workshop
Country/Territory	Austria
City	Vienna
Period	08/09/2021 → 11/09/2021

Documents & Links

10.1016/S2152-2650(21)02294-1

SDU Link

Check access to the material in SDU Library's search engine

Cite this

Moore, K. L. F., Blimark, C. H., Vangsted, A. J., Turesson, I., Klausen, T., Redder, L., Knut-Bojanowska, D., Sverrisdottir, I., & Genell, A. (2021). Real-world elderly myeloma patients: improved survival despite more adverse risk factors than younger patients and RCT populations. A study on behalf of the Nordic Myeloma Study Group. Clinical Lymphoma Myeloma and Leukemia, 21(Suppl. 2), S127-S128. Article P-167. https://doi.org/10.1016/S2152-2650(21)02294-1

@article{b37ee1ff7c2d4a1b88ba6f32545365fd,

title = "Real-world elderly myeloma patients: improved survival despite more adverse risk factors than younger patients and RCT populations. A study on behalf of the Nordic Myeloma Study Group",

author = "Moore, \{Kari Lenita Falck\} and Blimark, \{Cecilie Hveding\} and Vangsted, \{Annette Juul\} and Ingemar Turesson and Tobias Klausen and Louise Redder and Dorota Knut-Bojanowska and Ingigerdur Sverrisdottir and Anna Genell",

year = "2021",

month = oct,

doi = "10.1016/S2152-2650(21)02294-1",

language = "English",

volume = "21",

pages = "S127--S128",

journal = "Clinical Lymphoma Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Elsevier",

number = "Suppl. 2",

note = "18th International Myeloma Workshop ; Conference date: 08-09-2021 Through 11-09-2021",

}

Moore, KLF, Blimark, CH, Vangsted, AJ, Turesson, I, Klausen, T, Redder, L, Knut-Bojanowska, D, Sverrisdottir, I & Genell, A 2021, 'Real-world elderly myeloma patients: improved survival despite more adverse risk factors than younger patients and RCT populations. A study on behalf of the Nordic Myeloma Study Group', Clinical Lymphoma Myeloma and Leukemia, vol. 21, no. Suppl. 2, P-167, pp. S127-S128. https://doi.org/10.1016/S2152-2650(21)02294-1

Real-world elderly myeloma patients: improved survival despite more adverse risk factors than younger patients and RCT populations. A study on behalf of the Nordic Myeloma Study Group. / Moore, Kari Lenita Falck; Blimark, Cecilie Hveding; Vangsted, Annette Juul et al.
In: Clinical Lymphoma Myeloma and Leukemia, Vol. 21, No. Suppl. 2, P-167, 10.2021, p. S127-S128.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Real-world elderly myeloma patients: improved survival despite more adverse risk factors than younger patients and RCT populations. A study on behalf of the Nordic Myeloma Study Group

AU - Moore, Kari Lenita Falck

AU - Blimark, Cecilie Hveding

AU - Vangsted, Annette Juul

AU - Turesson, Ingemar

AU - Klausen, Tobias

AU - Redder, Louise

AU - Knut-Bojanowska, Dorota

AU - Sverrisdottir, Ingigerdur

AU - Genell, Anna

PY - 2021/10

Y1 - 2021/10

U2 - 10.1016/S2152-2650(21)02294-1

DO - 10.1016/S2152-2650(21)02294-1

M3 - Conference abstract in journal

SN - 2152-2650

VL - 21

SP - S127-S128

JO - Clinical Lymphoma Myeloma and Leukemia

JF - Clinical Lymphoma Myeloma and Leukemia

IS - Suppl. 2

M1 - P-167

T2 - 18th International Myeloma Workshop

Y2 - 8 September 2021 through 11 September 2021

ER -

Moore KLF, Blimark CH, Vangsted AJ, Turesson I, Klausen T, Redder L et al. Real-world elderly myeloma patients: improved survival despite more adverse risk factors than younger patients and RCT populations. A study on behalf of the Nordic Myeloma Study Group. Clinical Lymphoma Myeloma and Leukemia. 2021 Oct;21(Suppl. 2):S127-S128. P-167. doi: 10.1016/S2152-2650(21)02294-1